SLC2A10
Basic information
Region (hg38): 20:46709649-46736347
Links
Phenotypes
GenCC
Source:
- arterial tortuosity syndrome (Definitive), mode of inheritance: AR
- arterial tortuosity syndrome (Strong), mode of inheritance: AR
- arterial tortuosity syndrome (Supportive), mode of inheritance: AR
- arterial tortuosity syndrome (Definitive), mode of inheritance: AR
- arterial tortuosity syndrome (Strong), mode of inheritance: AR
- familial thoracic aortic aneurysm and aortic dissection (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Arterial tortuosity syndrome | AR | Cardiovascular | Individuals appear to be at increased risk of cradiovascular manifestations, such as ischemic events, arterial aneurysm, and other findings, and preventive measures and prompt treatment may be beneficial | Cardiovascular; Dermatologic; Genitourinary; Musculoskeletal; Renal | 6033167; 12801113; 16550171; 17935213; 18565096; 19508422; 19781076; 29323665 |
ClinVar
This is a list of variants' phenotypes submitted to
- Arterial tortuosity syndrome (10 variants)
- Familial thoracic aortic aneurysm and aortic dissection (3 variants)
- not provided (3 variants)
- SLC2A10-related disorder (1 variants)
- Cardiovascular phenotype (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC2A10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 140 | 140 | ||||
missense | 230 | 251 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 13 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 4 | 4 | 8 | |||
non coding | 43 | 45 | 29 | 117 | ||
Total | 12 | 20 | 276 | 194 | 33 |
Highest pathogenic variant AF is 0.000118
Variants in SLC2A10
This is a list of pathogenic ClinVar variants found in the SLC2A10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-46709677-G-T | Arterial tortuosity syndrome | Uncertain significance (Jan 13, 2018) | ||
20-46709682-G-T | Arterial tortuosity syndrome | Uncertain significance (Jan 13, 2018) | ||
20-46709706-G-GC | not specified | Likely benign (Apr 03, 2017) | ||
20-46709710-C-T | not specified • Arterial tortuosity syndrome | Benign (Jan 12, 2018) | ||
20-46709715-A-G | Arterial tortuosity syndrome | Conflicting classifications of pathogenicity (Jan 13, 2018) | ||
20-46709722-C-T | not specified • Arterial tortuosity syndrome • Familial thoracic aortic aneurysm and aortic dissection | Conflicting classifications of pathogenicity (Apr 30, 2024) | ||
20-46709727-C-G | SLC2A10-related disorder | Likely benign (Jun 29, 2022) | ||
20-46709737-A-G | Arterial tortuosity syndrome | Conflicting classifications of pathogenicity (Mar 26, 2024) | ||
20-46709737-A-T | Familial thoracic aortic aneurysm and aortic dissection | Likely pathogenic (Apr 17, 2024) | ||
20-46709740-G-A | Arterial tortuosity syndrome | Uncertain significance (May 27, 2022) | ||
20-46709746-T-A | Familial thoracic aortic aneurysm and aortic dissection | Uncertain significance (Jun 30, 2021) | ||
20-46709749-C-G | not specified • Arterial tortuosity syndrome | Likely benign (Jun 24, 2024) | ||
20-46709750-G-A | Arterial tortuosity syndrome | Likely benign (Sep 09, 2023) | ||
20-46709754-G-C | Arterial tortuosity syndrome | Likely benign (Dec 23, 2022) | ||
20-46709754-G-T | Arterial tortuosity syndrome | Likely benign (Jan 29, 2022) | ||
20-46709968-C-T | Likely benign (Aug 03, 2018) | |||
20-46724806-AGGAT-A | Benign (Aug 06, 2019) | |||
20-46724806-A-AGGAT | Benign (Nov 14, 2019) | |||
20-46724875-C-CGGACGGAT | Likely benign (Sep 21, 2019) | |||
20-46724875-C-CGGATGGAT | Benign (Nov 14, 2019) | |||
20-46724875-C-CGGATGGATGGATGGAT | Benign (Aug 10, 2019) | |||
20-46724875-C-CGGATGGATGGAT | Benign (Nov 14, 2019) | |||
20-46724905-GTTTGA-G | Likely benign (Aug 06, 2019) | |||
20-46724918-G-GT | Likely benign (Jun 14, 2018) | |||
20-46724925-A-G | Likely benign (Jun 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC2A10 | protein_coding | protein_coding | ENST00000359271 | 5 | 26840 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.57e-8 | 0.225 | 125694 | 0 | 54 | 125748 | 0.000215 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.755 | 338 | 301 | 1.12 | 0.0000191 | 3399 |
Missense in Polyphen | 115 | 112.48 | 1.0224 | 1316 | ||
Synonymous | -1.53 | 162 | 139 | 1.17 | 0.00000886 | 1295 |
Loss of Function | 0.435 | 13 | 14.8 | 0.878 | 8.37e-7 | 160 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000608 | 0.000608 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000282 | 0.000281 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Facilitative glucose transporter.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;SLC-mediated transmembrane transport;Transport of small molecules;Fructose and mannose metabolism;Galactose metabolism;Cellular hexose transport
(Consensus)
Recessive Scores
- pRec
- 0.180
Intolerance Scores
- loftool
- 0.217
- rvis_EVS
- 0.23
- rvis_percentile_EVS
- 68.52
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.291
- ghis
- 0.481
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.561
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc2a10
- Phenotype
- renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- slc2a10
- Affected structure
- vasculature
- Phenotype tag
- abnormal
- Phenotype quality
- irregular spatial pattern
Gene ontology
- Biological process
- hexose transmembrane transport;proton transmembrane transport;glucose transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;endomembrane system;integral component of membrane;perinuclear region of cytoplasm
- Molecular function
- carbohydrate:proton symporter activity;D-glucose transmembrane transporter activity